SynthesisFrontiers in cardiovascular medicine2026
Artificial intelligence technology in aortic valve disease: a decade of scientometric and narrative review.
Synthesis in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aortic valve disease, particularly aortic stenosis, poses a growing global health burden with aging populations. Artificial intelligence technology offers promising tools for diagnosis, risk stratification, and prognosis prediction, yet the knowledge structure of this interdisciplinary field remains unsystematically characterized. Objective: This study aims to conduct a scientometric analysis to delineate the research landscape, identify hotspots, and trace evolutionary trends of AI technology applications in aortic valve disease over the past decade. Methods: We retrieved relevant literature published between January 2016 and January 2026 from the Web of Science Core Collection and Scopus databases. After screening, 270 eligible articles were included. CiteSpace and VOSviewer were employed to perform visualization analyses of authors, institutions, countries, journals, keywords, and co-citation networks. Results: Annual publications increased steadily, with the United States leading in both output and influence. The Mayo Clinic emerged as the most prolific institution. Research hotspots focused on AI-assisted diagnosis, risk stratification, and prognosis prediction for aortic stenosis, primarily using deep learning and machine learning techniques. Keyword clustering revealed themes spanning disease diagnosis, therapeutic technologies, AI-enabled applications, and clinical outcomes. Co-citation analysis highlighted key studies on AI-enhanced electrocardiography and echocardiography for valve disease detection. Conclusions: AI technology research in aortic valve disease is advancing rapidly. Based on the keyword clustering and timeline analysis, we propose a conceptual mapping of AI techniques onto clinical phases. Future efforts should prioritize developing multimodal models, facilitating clinical integration, and enhancing patient lifecycle management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.